EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA methylation episignature for White-Sutton syndrome due to POGZ variants

Sadegheh Haghshenas, Brittany N Simpson, Amelle Shillington, Aurore Garde, Aidin Foroutan, Michael A Levy, Raissa Relator, Pratibha Bhai, Jennifer Kerkhof, Haley McConkey, Frederic Tran Mau-Them, Ange Line Bruel und 32 weitere

Genetics in Medicine Open · 2026 · 4 · 104489

DOI: 10.1016/j.gimo.2026.104489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics in Medicine Open, 2026. Verfasst von Sadegheh Haghshenas und 43 weiteren Autor:innen. Beteiligte Einrichtung: Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ontario Genomics Institute, Genome Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

White-Sutton syndrome (WHSUS) is a rare, autosomal dominant neurodevelopmental disorder (NDD) caused by heterozygous loss-of-function alterations in the POGZ gene. WHSUS exhibits variable expressivity, often overlapping with other NDDs. In this study, we characterized a distinct DNA methylation epigenetic signature (episignature) that differentiates WHSUS from unaffected individuals, as well as from individuals with other NDDs that also have episignatures, using a cohort of both published and unpublished cases of POGZ haploinsufficiency.

Methods

Thirteen DNA samples from the peripheral blood of individuals with pathogenic or likely pathogenic heterozygous alterations in POGZ were used to identify the episignature and develop a predictive diagnostic biomarker. The diagnostic model, validated with 4 samples from confirmed WHSUS cases, was then applied to investigate the methylation patterns in 7 individuals with variants of uncertain significance in POGZ.

Results

Using genome-wide DNA methylation analysis, a predominantly hypomethylated DNA methylation profile specific to WHSUS was identified. A sensitive and specific classifier model was then constructed based on this profile. Gene set enrichment analysis revealed terms related to various cellular processes, and functional correlation analysis indicated potential common pathways with other genetic disorders.

Conclusion

We identified a novel and robust episignature in WHSUS caused by POGZ haploinsufficiency. This episignature facilitates the identification and diagnosis of individuals with WHSUS, as well as the reclassification of variants of uncertain significance associated with this condition.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationEpigeneticsPOGZWHSUSWhite-Sutton syndrome

Autor:innen und Institutionen

  • Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada.
  • Cincinnati Children's Hospital Medical Center: Division of Human Genetics, United States; Cincinnati Children's Hospital Medical Center: Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati…
  • Université Bourgogne Europe, CHU Dijon Bourgogne, Inserm, CTM UMR1231, équipe GAD, FHU TRANSLAD, Centre de génétique, Centre de référence Anomalies du Développement et Syndromes Malformatifs, Centre de référence Déficie…
  • Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.
  • Université Bourgogne Europe, CHU Dijon Bourgogne, Laboratoire de Génomique Médicale, Centre Neomics, FHU TRANSLAD, Centre de recherche Translationnelle en Médecine moléculaire - Inserm UMR1231, équipe GAD, Dijon, France.
  • Centre de Référence Anomalies du Développement et Syndromes Malformatifs, CHU Caen, Caen, France.

Förderung

  • Ontario Genomics Institute
  • Genome Canada

Zitieren

APA

Haghshenas, S., Simpson, B. N., Shillington, A., Garde, A., Foroutan, A., Levy, M. A., Relator, R., Bhai, P., Kerkhof, J., McConkey, H., Mau-Them, F. T., Bruel, A. L., Philippe, C., Denommé-Pichon, A. S., Safraou, H., Vincent, A., Patat, O., Prieur, F., Perrin, L., …, & Faivre, L. (2026). DNA methylation episignature for White-Sutton syndrome due to POGZ variants. Genetics in Medicine Open, 4, 104489. https://doi.org/10.1016/j.gimo.2026.104489

Vancouver

Haghshenas S, Simpson BN, Shillington A, Garde A, Foroutan A, Levy MA, et al. DNA methylation episignature for White-Sutton syndrome due to POGZ variants. Genetics in Medicine Open. 2026;4:104489. doi:10.1016/j.gimo.2026.104489

BibTeX
@article{Haghshenas2026,
  author = {Haghshenas, Sadegheh and Simpson, Brittany N and Shillington, Amelle and Garde, Aurore and Foroutan, Aidin and Levy, Michael A and Relator, Raissa and Bhai, Pratibha and Kerkhof, Jennifer and McConkey, Haley and Mau-Them, Frederic Tran and Bruel, Ange Line and Philippe, Christophe and Denommé-Pichon, Anne-Sophie and Safraou, Hana and Vincent, Aline and Patat, Olivier and Prieur, Fabienne and Perrin, Laurence and Coubes, Christine and Isidor, Bertrand and Fradin, Melanie and Toutain, Annick and Mazel, Benoit and Kuentz, Paul and Delanne, Julian and Thauvin-Robinet, Christel and De Souza, Clément Simao and Racine, Caroline and Merla, Giuseppe and Gerard, Marion and Gruchy, Nicolas and Colson, Cindy and Alders, Marielle and Maas, Saskia and Tedder, Matthew L and Patterson, Wesley G and Salzano, Emanuela and Orozco, Emi Rikeros and Miñaúr, Sixto García and Palomares-Bralo, María and Vitobello, Antonio and Sadikovic, Bekim and Faivre, Laurence},
  title = {DNA methylation episignature for White-Sutton syndrome due to POGZ variants},
  journal = {Genetics in Medicine Open},
  year = {2026},
  volume = {4},
  pages = {104489},
  doi = {10.1016/j.gimo.2026.104489}
}
Kostenlos starten →